ClinVar Miner

Submissions for variant NM_000302.4(PLOD1):c.702C>G (p.Asp234Glu)

dbSNP: rs566018612
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000801788 SCV000941583 likely benign Ehlers-Danlos syndrome, kyphoscoliotic type 1 2023-12-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV002360952 SCV002662008 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2022-05-02 criteria provided, single submitter clinical testing The p.D234E variant (also known as c.702C>G), located in coding exon 7 of the PLOD1 gene, results from a C to G substitution at nucleotide position 702. The aspartic acid at codon 234 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GenomeConnect - Invitae Patient Insights Network RCV000801788 SCV001749486 not provided Ehlers-Danlos syndrome, kyphoscoliotic type 1 no assertion provided phenotyping only Variant interpreted as Uncertain significance and reported on 08-03-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.